We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Publishes Action Plan to Streamline Gene Therapy Development and Review
EMA Publishes Action Plan to Streamline Gene Therapy Development and Review
The European Medicines Agency launched a new plan to streamline procedures for developing advanced gene and cell therapies, including adapting manufacturing requirements to products’ specific challenges.